These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9163660)

  • 1. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test.
    Delmarco A; Pradal U; Cabrini G; Bonizzato A; Mastella G
    Eur Respir J; 1997 May; 10(5):1145-9. PubMed ID: 9163660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
    Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
    Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?
    Ooi CY; Dupuis A; Ellis L; Jarvi K; Martin S; Ray PN; Steele L; Kortan P; Gonska T; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
    Thorax; 2014 Mar; 69(3):254-60. PubMed ID: 24149827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of nasal potential difference in diagnosis of cystic fibrosis among children.
    Valiulis A; Skurvydienė I; Misevičienė V; Kasnauskienė J; Vaidelienė L; Utkus A
    Medicina (Kaunas); 2013; 49(4):185-90. PubMed ID: 23985983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
    Sermet-Gaudelus I; Girodon E; Sands D; Stremmler N; Vavrova V; Deneuville E; Reix P; Bui S; Huet F; Lebourgeois M; Munck A; Iron A; Skalicka V; Bienvenu T; Roussel D; Lenoir G; Bellon G; Sarles J; Macek M; Roussey M; Fajac I; Edelman A
    Am J Respir Crit Care Med; 2010 Oct; 182(7):929-36. PubMed ID: 20538955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism.
    Aalbers BL; Yaakov Y; Derichs N; Simmonds NJ; De Wachter E; Melotti P; De Boeck K; Leal T; Tümmler B; Wilschanski M; Bronsveld I
    J Cyst Fibros; 2020 Jul; 19(4):627-631. PubMed ID: 31331863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
    Hubert D; Fajac I; Bienvenu T; Desmazes-Dufeu N; Ellaffi M; Dall'ava-Santucci J; Dusser D
    J Cyst Fibros; 2004 Mar; 3(1):15-22. PubMed ID: 15463882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal potential difference measurements in patients with atypical cystic fibrosis.
    Wilschanski M; Famini H; Strauss-Liviatan N; Rivlin J; Blau H; Bibi H; Bentur L; Yahav Y; Springer H; Kramer MR; Klar A; Ilani A; Kerem B; Kerem E
    Eur Respir J; 2001 Jun; 17(6):1208-15. PubMed ID: 11491166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal potential difference in cystic fibrosis considering severe CFTR mutations.
    Ng RT; Marson FA; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Ribeiro MA; Severino SD; Sakano E
    Dis Markers; 2015; 2015():306825. PubMed ID: 25667564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.
    Tridello G; Menin L; Pintani E; Bergamini G; Assael BM; Melotti P
    J Cyst Fibros; 2016 Sep; 15(5):579-82. PubMed ID: 27423539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
    Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests.
    Augarten A; Shmilovich H; Doolman R; Aviram M; Akons H; Ben Tur L; Blau H; Kerem E; Rivlin J; Sela BA; Szeinberg A; Yahav Y
    Pediatr Pulmonol; 2000 Oct; 30(4):320-3. PubMed ID: 11015133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of nasal potential difference measurements in cystic fibrosis.
    Yaakov Y; Kerem E; Yahav Y; Rivlin J; Blau H; Bentur L; Aviram M; Picard E; Bdolah-Abram T; Wilschanski M
    Chest; 2007 Oct; 132(4):1219-26. PubMed ID: 17890478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive
    Minso R; Schulz A; Dopfer C; Alfeis N; Barneveld AV; Makartian-Gyulumyan L; Hansen G; Junge S; Müller C; Ringshausen FCC; Sauer-Heilborn A; Stanke F; Stolpe C; Tamm S; Welte T; Dittrich AM; Tümmler B
    BMJ Open Respir Res; 2020 Oct; 7(1):. PubMed ID: 33020115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of cystic fibrosis.
    De Boeck K; Vermeulen F; Dupont L
    Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
    Padoan R; Bassotti A; Seia M; Corbetta C
    Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.
    Mainz J; Hammer U; Rokahr C; Hubler A; Zintl F; Ballmann M
    Respiration; 2006; 73(5):698-704. PubMed ID: 16763370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified method to measure nasal potential difference.
    Leal T; Lebacq J; Lebecque P; Cumps J; Wallemacq P
    Clin Chem Lab Med; 2003 Jan; 41(1):61-7. PubMed ID: 12636051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.